3 US Healthcare Stocks Show Bullish Momentum
Three US Healthcare stocks, BDX, BMY, and COO, just flipped to bullish Altra Scores, signaling potential sector shifts.
- Visit the stock pages: BDX, BMY, COO
- Sector USHEALTHCARE , which ranks #3 for Relative Strength (Altra Sector score of 65.0 with bearish regime.)
The US Healthcare sector, which has been signaling a lagging trend, is now seeing notable shifts in individual stock momentum, with Becton Dickinson (BDX), Bristol Myers Squibb (BMY), and Cooper Companies (COO) all transitioning to bullish Altra Scores in a single session. This collective movement suggests that despite the sector’s overall bearish Altra Sector score of 65.0 (ranked 3rd), there might be a nascent turn, as indicated by the starting to turn up regime detail.
The Altra Score is a momentum metric, ranging from 0 to 100, that quantifies a stock’s bullish or bearish sentiment. A higher score, derived from the alignment of Exponential Moving Averages (EMAs) and the trend of the Relative Strength Index (RSI) across daily, weekly, and monthly timeframes, points to stronger upward momentum. The broader market itself is currently showing an Improving Altra Market score of 57.1, with market breadth indicating 52.88% of stocks above their 20-day EMA and 59.44% above their 50-day EMA, suggesting traders remain selective, favoring high-quality setups. An Altra Market score is the same kind of score applied market-wide, representing the percentage of stocks above key EMAs, providing a read on overall market breadth or texture. Similarly, an Altra Sector score applies this analysis at the sector level, offering insight into a sector's momentum and its relative strength rank against other sectors.
BDX - Becton Dickinson
Becton Dickinson (BDX) has experienced a significant shift in its momentum, with its Altra Score jumping from 22.5 to 84.9. This substantial move has upgraded its regime from Bearish to Strong Bullish. The stock’s EMAs are now placed above key EMAs, a foundational signal of improving trend. Looking at its Relative Strength Index (RSI), the daily RSI sits at 55.89, with the weekly at 51.37, indicating increasing buying pressure without being overextended. However, it's worth noting the presence of a bearish Weekly EMA Crossover on 2026-05-01, which technical analysts often monitor for potential resistance or consolidation points. Despite this, the strong surge in its Altra Score indicates that short-term momentum has overcome previous bearish signals, pushing the stock into a Strong Bullish stance.
BMY - Bristol Myers Squibb
Bristol Myers Squibb (BMY) also demonstrated a robust momentum reversal, seeing its Altra Score catapult from 38.9 to 90.1, moving from Bearish straight to Strong Bullish. This powerful shift positions BMY with one of the highest individual scores among these three stocks. Its EMAs are also comfortably placed above key EMAs, affirming a positive price trend. The RSI readings across multiple timeframes – daily at 55.31, weekly at 55.59, and monthly at 58.41 – all suggest healthy upward momentum and sustained buying interest. Unlike BDX, BMY notably experienced a bullish Weekly EMA Crossover back on 2025-12-05, indicating that its positive trend might be more established and has now intensified to a Strong Bullish Altra Score.
COO - Cooper Companies (The)
Cooper Companies (COO) has made a considerable leap from a Strong Bearish regime, with its Altra Score rising from 14.6 to 65.5, placing it firmly in a Bullish regime. This marks a significant turnaround from its prior deeply bearish sentiment. The stock's EMAs are now situated above key EMAs, reflecting recent price appreciation. Its daily RSI of 55.04 and weekly RSI of 50.37 point to growing positive momentum. Similar to BDX, COO has an existing bearish Weekly EMA Crossover from 2026-03-20. While such crossovers can denote periods of weakness, the recent rebound in the Altra Score suggests a renewed push from buyers, signaling a potential shift in the underlying trend despite the older bearish crossover. This turnaround indicates that the short-term dynamics for COO have improved substantially.
Collectively, these three US Healthcare stocks offer a glimpse into a sector that, while still broadly ranked 3rd and designated bearish by its Altra Sector score, is showing early signs of internal strength. The Altra Sector, which provides a momentum score at the industry level and ranks it against others, shows the sector’s RS 4w trend improving by +0.05 and its RS RSI at 51.2, suggesting that the lagging sentiment might be starting to dissipate. The simultaneous bullish momentum shifts in BDX, BMY, and COO within the same session could be an early indicator for active investors monitoring the US Healthcare space for potential high-probability setups.
What is the Altra Score? The Altra Score is AltraOne's proprietary momentum score for individual stocks, ranging from 0 to 100. It measures EMA structure and RSI momentum across multiple timeframes. A score above 60 is Bullish, below 40 is Bearish, and 40–60 is Neutral. The score is updated every trading day after market close based on end-of-day data.
Explore the full Signal History on AltraOne to see every EMA crossover signal across your watchlist — going back 52 weeks. The weekly EMA crossover is AltraOne's highest-conviction intermediate momentum signal; the Signal History page lets you track how these have played out over time.
Altra Score is a momentum indicator reflecting EMA alignment and RSI trend across daily, weekly, and monthly timeframes. It is not investment advice. Past momentum does not guarantee future performance. Please consult a SEBI-registered advisor before making investment decisions.